Ibogaine Safety Floor
Safety Floor · Do Not Skip
Ibogaine can kill you if handled wrong. At least 27 documented fatalities exist in the global medical literature. Almost all were cardiac, and almost all were preventable.
These nine questions separate a modern medically supervised ibogaine protocol from expensive negligence. Print this list. Take it to every clinic conversation. If a clinic refuses to answer any of these questions in writing, do not book.
Why this is about cardiac safety, specifically
Ibogaine blocks the hERG potassium channel and prolongs the cardiac QT interval. In vulnerable people, this can trigger a fatal arrhythmia called torsades de pointes, which can collapse into ventricular fibrillation within seconds.
Stanford's MISTIC trial of 30 special-operations veterans had zero serious adverse events under continuous telemetry with IV magnesium coadministration. The underground-provider record is not the same. The difference is the protocol below.
The Nine Questions
-
1
Do you require a 12-lead EKG with calculated QTc prior to admission?
And at what QTc cutoff will you decline to treat? A real clinic will have a written policy (e.g., QTc > 450 ms in men or > 470 ms in women is a hard decline). If they do not measure QTc, they cannot screen for the exact risk that has killed almost everyone who has died from ibogaine.
-
2
Do you require a full electrolyte panel — sodium, potassium, magnesium, calcium — with repletion of any deficiency before dosing?
Low magnesium and low potassium both prolong the QT interval on top of ibogaine. Any clinic that does not replete to full normal ranges before dosing is gambling with your cardiac conduction system.
-
3
Do you require liver function tests (AST, ALT, bilirubin) and will you decline treatment at specific thresholds?
Ibogaine is metabolized by the liver (primarily CYP2D6). Impaired liver function means higher circulating drug, longer half-life, longer cardiac exposure. LFTs are non-negotiable.
-
4
Do you test or genotype for CYP2D6 status, and how do you adjust dosing for poor metabolizers?
Roughly 5 to 10 percent of people of European descent are CYP2D6 poor metabolizers. They have dramatically higher ibogaine exposure at the same dose and elevated cardiac risk. Best-practice clinics genotype. Acceptable practice at minimum asks detailed family history of drug-metabolism issues and reduces dose when uncertain.
-
5
What is your mandatory washout period for SSRIs, SNRIs, MAOIs, methadone, and other QT-prolonging medications?
Expect weeks, not days. Fluoxetine (Prozac) alone requires 4 to 6 weeks of washout because of its long active metabolite. Methadone washout is contentious and must be managed by a physician — stopping cold is dangerous, but residual methadone during ibogaine dosing is also dangerous. If a clinic handwaves washout, leave.
-
6
Do you administer IV magnesium sulfate pre- and intra-dose, and at what protocol?
This is the single intervention most strongly associated with the zero-serious-adverse-event record of Stanford's MISTIC cohort (N=30). Magnesium shortens the QT interval and provides a buffer against torsades de pointes. This is the modern safety standard and its absence is disqualifying.
-
7
Is continuous cardiac telemetry maintained through the entire 18- to 36-hour acute phase, and is the monitoring physician ACLS-certified?
Not pulse oximetry. Not intermittent nursing checks. Continuous multi-lead EKG with automated arrhythmia alarms and a physician trained in Advanced Cardiac Life Support on site. Peak cardiac risk is not at dose — it extends through the full tail of the experience as noribogaine accumulates.
-
8
Do you have an onsite crash cart, functional defibrillator, and a written hospital transfer agreement with response time under 10 minutes?
Torsades can collapse into ventricular fibrillation in seconds. Defibrillation must be immediate. A written agreement (not a verbal assurance) with a local hospital for emergency transfer is what separates a medical facility from an expensive yoga retreat.
-
9
Where is your ibogaine sourced — semi-synthetic from voacangine, Nagoya-Protocol-compliant Gabonese iboga, or undisclosed?
Over 90 percent of Western ibogaine is from poached wild iboga in Gabon. This is both ethically indefensible — iboga is strategic national heritage and sacred to the Bwiti tradition — and a quality risk, because unregulated supply chains produce inconsistent purity. Reputable clinics source from semi-synthetic routes (voacangine from Voacanga africana, which is abundant) or from the handful of Nagoya-compliant Gabonese exporters like Blessings of the Forest. If a clinic refuses to answer, they are telling you the answer.
Hard Contraindications
If any of the following apply to you, ibogaine is contraindicated. Not relatively cautioned. Not handled with extra monitoring. Contraindicated.
- Any history of cardiac arrhythmia, long QT syndrome, or sudden cardiac death in family
- Current use of SSRIs, SNRIs, MAOIs, methadone, or QT-prolonging antibiotics without full supervised washout
- Pregnancy or active breastfeeding
- Liver disease (elevated LFTs, hepatitis, cirrhosis)
- Uncontrolled hypertension or recent cardiac event
- Active psychosis or untreated bipolar disorder (manic phase)
- CYP2D6 poor metabolizer status without dose adjustment
What a Reputable Clinic Looks Like
- Cardiology-trained medical director or board-certified physician specifically credentialed in ibogaine protocols.
- Written intake packet covering labs, washout schedule, consent, and emergency protocols — not a verbal summary.
- On-site continuous telemetry with automated arrhythmia alerts and an ACLS-certified physician present throughout the acute phase.
- IV magnesium loading per the MISTIC protocol and repletion of any baseline electrolyte deficiency.
- Structured post-session integration with documented follow-up at 30, 90, and 180 days — especially for opioid use disorder patients, where overdose risk from reset tolerance is the leading cause of post-treatment death.
- Transparent sourcing of ibogaine — either semi-synthetic from voacangine or Nagoya-Protocol-compliant Gabonese supply. Ask to see the certificate.
Our Position
Ibogaine is simultaneously one of the most clinically promising single interventions ever documented for opioid dependency and combat-related TBI, and one of the most dangerous compounds if administered outside a proper clinical setting. Both facts are true at once.
Our job is to hold both honestly. These nine questions are the operational safety floor. Nothing below this bar should be called medicine.
Read the full ibogaine briefing →
This page is educational and does not constitute medical advice. Decisions about ibogaine treatment should be made with a licensed physician familiar with the compound, your personal medical history, and current evidence. We do not endorse specific clinics and do not profit from any clinic referral.